Literature DB >> 25031043

Synthesis and crystal structure of 6-fluoro-3-hydroxypyrazine-2-carboxamide.

Fangyuan Shi1, Zongtao Li, Lingjin Kong, Yuanchao Xie, Tao Zhang, Wenfang Xu.   

Abstract

As a RNA polymerase inhibitor, 6-fluoro-3-hydroxypyrazine-2-carboxamide commercially named favipiravir has been proved to have potent inhibitory activity against RNA viruses in vitro and in vivo. A four-step synthesis of the compound is described in this article, amidation, nitrification, reduction and fluorination with an overall yield of about 8%. In addition, we reported the crystal structure of the title compound. The molecule is almost planar and the intramolecular O-H(•••)O hydrogen bond makes a 6-member ring. In the crystal, molecules are packing governed by both hydrogen bonds and stacking interactions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25031043     DOI: 10.5582/ddt.2014.01028

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  6 in total

1.  Favipiravir - a Modern Antiviral Drug: Synthesis and Modifications.

Authors:  Yulia A Titova; Olga V Fedorova
Journal:  Chem Heterocycl Compd (N Y)       Date:  2020-07-16       Impact factor: 1.277

2.  Scalable synthesis of favipiravir via conventional and continuous flow chemistry.

Authors:  Thanat Tiyasakulchai; Netnapa Charoensetakul; Thitiphong Khamkhenshorngphanuch; Chawanee Thongpanchang; Onsiri Srikun; Yongyuth Yuthavong; Nitipol Srimongkolpithak
Journal:  RSC Adv       Date:  2021-12-01       Impact factor: 3.361

3.  Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19.

Authors:  Letícia Cristina Assis; Alexandre Alves de Castro; João Paulo Almirão de Jesus; Elaine Fontes Ferreira da Cunha; Eugenie Nepovimova; Ondrej Krejcar; Kamil Kuca; Teodorico Castro Ramalho; Felipe de Almeida La Porta
Journal:  RSC Adv       Date:  2021-11-01       Impact factor: 4.036

4.  Favipiravir and Its Structural Analogs: Antiviral Activity and Synthesis Methods.

Authors:  I D Konstantinova; V L Andronova; I V Fateev; R S Esipov
Journal:  Acta Naturae       Date:  2022 Apr-Jun       Impact factor: 2.204

5.  Trivalent and pentavalent atoms doped boron nitride nanosheets as Favipiravir drug carriers for the treatment of COVID-19 using computational approaches.

Authors:  Afiya Akter Piya; Tanvir Ahmed; Md Abdul Khaleque; Kabir Ahmed; Siraj Ud Daula Shamim
Journal:  Comput Theor Chem       Date:  2022-09-30       Impact factor: 2.292

Review 6.  A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2.

Authors:  Prerna Malik; Sonika Jain; Pankaj Jain; Jyoti Kumawat; Jaya Dwivedi; Dharma Kishore
Journal:  Arch Pharm (Weinheim)       Date:  2022-01-17       Impact factor: 4.613

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.